Therapy Cool Path Ablation Catheter & IBI 1500T9
FDA PMAClass III (US FDA PMA)
Identity
- Trade Name
- IBI THERAPY COOL PATH ABLATION CATHETER & IBI-1500T9 RF FDA PMA
- Generic Name
- catheter, percutaneous, cardiac ablation, for treatment of atrial flutter FDA PMA
Identifiers
- PMA Number
- P060019 FDA PMA
- FDA Product Code
- OAD FDA PMA
Classification
- Device Class
- Class III FDA PMA
- Advisory Committee
- Cardiovascular FDA PMA
- FDA Decision
- APPR Approved FDA PMA
The Therapy Cool Path Ablation Catheter & IBI 1500T9 is a percutaneous cardiac ablation catheter system intended for use with a compatible external infusion pump and the IBI 1500T9 radiofrequency (RF) generator at a maximum of 50 watts. It is designed for creating endocardial lesions during cardiac ablation procedures (mapping, stimulation and ablation) for the treatment of typical atrial flutter.
The system requires a compatible external infusion pump when used with the Therapy Cool Path catheter. The IBI 1500T9 RF ablation generator is internally limited to 50 watts when used with these catheters and is intended for use with compatible St. Jude Medical temperature-controlled ablation catheters to treat cardiac arrhythmias including supraventricular tachycardias and atrial flutter. The device is supplied as a single-use system and has received FDA PMA approval (P060019).
Frequently asked questions
What is the maximum power setting for the IBI 1500T9 generator when used with the Therapy Cool Path catheter?
The IBI 1500T9 RF ablation generator is internally limited to 50 watts when used with the Therapy Cool Path catheters, as specified in the approval documentation.
Is an external infusion pump required when using the Therapy Cool Path catheter with the IBI 1500T9 generator?
Yes, a compatible external infusion pump must be connected when using the Therapy Cool Path catheter with the IBI 1500T9 RF ablation generator, as stated in the device's approval conditions.
What cardiac condition is the Therapy Cool Path Ablation Catheter & IBI 1500T9 system intended to treat?
The system is intended for the treatment of typical atrial flutter by creating endocardial lesions during cardiac ablation procedures that include mapping, stimulation, and ablation.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.
Authorization Coverage (1 country)
Regulatory Authorizations
FDA_PMA
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA PMA | United States | FDA_PMA | P060019 | Class III | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Irvine Biomedical, Inc.
Sources (1)
- FDA PMA P060019 24 fields · synced Sep 18, 2026